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Abstract 
In this study, we examined the effect of TNF-o~ on mesangial cell gene expression of M-CSF, a colony-stimulating factor associated 
with monocyte differentiation into macrophages and proliferation. Incubation of mesangial cells with TNF-a-stimulated mRNA 
expression and protein synthesis of M-CSF. Mesangial cell activation with PMA, a PKC activator, stimulated M-CSF mRNA expression 
while PKC depletion decreased M-CSF mRNA expression to control evels. Stimulation of PKC-depleted mesangial cells with either 
PMA or TNF-et inhibited M-CSF mRNA transcripts. Preincubation of mesangial cells with calphostin C, a PKC inhibitor, reduced both 
PMA- and TNF-ct-induced M-CSF mRNA transcripts. Specific protein tyrosine kinase inhibitors blocked TNF-et-induced mesangial cell 
M-CSF mRNA expression. Additional studies showed that pertussis toxin, isoproterenol, and dibutyryl (db)cAMP did not induce 
mesangial cell M-CSF gene expression. However, coincubation of mesangial cells with TNF-ct and either dbcAMP, forskolin, or pertussis 
toxin inhibited TNF-a-induced M-CSF gene expression. Finally, TNF-et-activated mesangial cell conditioned media stimulated mono- 
cyte/macrophage proliferation dose-dependently and was prevented by using anti-M-CSF. These data suggested that M-CSF can regulate 
monocyte differentiation i to macrophages and proliferation within the mesangium induced by proinflammatory c tokines such as 
TNF-et. These cellular event.,; appeared to be modulated by signal transduction pathways mediated by PKC and PTK. 
Keywords: TNF-tx; M-CSF; Me,;angial cell; Monocyte; Protein kinase; Signal transduction 
1. Introduction 
The pathobiological cellular and molecular mechanisms 
resulting in glomerular injury that embody complex inter- 
actions involving resident glomerular cells, infiltrating in- 
fiammatory cells, and numerous cytokines [1-3]. Consid- 
erable experimental evidence implicates a prominent role 
that mesangial cells and circulating mononuclear phago- 
cytes have in the pathobiological mechanisms associated 
with the development of glomerulosclerosis. The unique 
central ocation of mesangial cells within the glomerulus, 
their contractibility characteristics, and their ability to form 
cytoplasmic processes or ]?seudopodia that project into the 
glomerular capillary lumen allow mesangial cells to inter- 
act with circulating mononuclear phagocytes and macro- 
molecules, and other biologically active chemical modula- 
tors. These properties facilitate mesangial cell regulation of 
* Corresponding author at address a.Fax: + 1 (310) 4945983. 
glomerular capillary blood flow, the filtration of macro- 
molecules and other plasma constituents across the 
glomerular capillary wall, and the transmigration of 
blood-borne cells into the mesangium [4]. 
Monocyte accumulation has been described in a variety 
of human and experimental models of immunological nd 
nonimmunological g omerular diseases [5-14]. Although 
the cellular and molecular mechanisms underlying mono- 
cyte infiltration into the glomerulus are not fully under- 
stood, monocyte recruitment and accumulation within the 
mesangium appears to be in response to a gradient of 
monocyte chemoattractants and other factors associated 
with monocyte differentiation i to macrophages and prolif- 
eration secreted by activated intrinsic glomerular cells 
[ 15,16]. In this regard, increased glomerular localization of 
monocyte chemotactic protein-I  (MCP-1)  and 
macrophage-colony stimulating factor (M-CSF) specific 
cytokines associated with monocyte infiltration, differenti- 
ation into macrophages and proliferation have been ob- 
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served in diverse experimental models of glomerular dis- 
ease [17-20]. 
M-CSF, is a major hematopoietic growth factor associ- 
ated with the chemoattraction, differentiation, maintenance 
and proliferation of mononuclear phagocytes in the early 
cellular esponse to glomerular injury [21,22]. M-CSF is a 
homodimeric glycoprotein synthesized by a variety of cell 
types including glomerular mesangial cells and promotes 
the growth and differentiation of bone marrow progenitor 
cells into mononuclear phagocytes and stimulates their 
proliferation and immune activation [21-25]. The observa- 
tion of a positive correlation between the severity of renal 
injury and the glomerular expression of M-CSF has pro- 
vided further evidence for a central role for this cytokine 
in elaborated monocyte infiltration and accumulation within 
the glomerulus associated with autoimmune-mediated re- 
nal injury [19,26]. However, the endogenous factor(s) that 
regulate the mesangial synthesis and release of these bio- 
logically active M-CSF molecules into the mesangial space 
that potentiate monocyte recruitment and proliferation have 
not been well characterized. 
Based on many in vivo and in vitro studies, it has been 
proposed that the activation of glomerular mesangial cells, 
in response to inflammatory cytokines, specifically, TNF- 
c~, can serve as a critical signaling molecule for the 
initiation and progression of monocyte infiltration into the 
mesangium and the pathogenesis of tissue inflammation 
and injury [27,28]. There is growing evidence that TNF-e~ 
is involved in the pathogenesis of glomerular injury both 
by its in vitro ability to induce cellular cytoregulatory 
peptides and by the observation that its systemic and 
glomerular expression is increased uring glomerular in- 
jury [28-32]. 
Despite numerous tudies howing that TNF-o~ induces 
various cytokines by both glomerular and nonglomerular 
cells, the cellular signaling pathways that regulate TNF-a- 
induced gene expression are not clearly understood. Thus, 
we examined the ability of exogenous TNF-a to influence 
the gene expression and protein synthesis of M-CSF by 
murine mesangial cells in an attempt to further define the 
role of TNF-a in the pathobiology of glomerular injury. 
Additional studies were performed to understand the multi- 
ple signal transduction pathways mediated through protein 
kinase C (PKC), protein tyrosine kinase (PTK) and cyclic- 
AMP involved in TNF-e~-induced cellular gene expression. 
2. Materials and methods 
2.1. Materials 
Dulbecco's minimal essential media (DMEM), RPMI 
1640, dibutyryl (db)cAMP, phorbol myristate acetate 
(PMA), histone and other tissue culture reagents were 
obtained from Sigma Chemical Company, St. Louis, MO. 
Fetal bovine serum (FBS) was obtained from Hyclone 
Laboratories Inc., Logan UT. Human recombinant TNF-c~ 
was purchased from R and D Systems, Minneapolis, MN. 
Murine anti-M-CSF and anti-PKCa were purchased from 
Oncogene Sciences, Manhasset, NY and Transduction 
Laboratories, Lexington, KY respectively, cDNA probes 
for murine M-CSF and human glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were purchased from American 
Type Culture Collection, (ATCC, Rockville, MD). Deoxy- 
cytidine-5'-[a-32p]triphosphate (spec. act. = 3000 
Ci/mmol), [ 3'- 32 P]ATP and [ methyl- 3H]thymidine (spec. 
act. = 2 Ci/mmol) were obtained from Amersham Corpo- 
ration, Arlington Heights, IL. MSI nylon transfer mem- 
branes were obtained from Fisher Scientific, Tustin, CA. 
Calphostin C, isoproterenol, pertussis toxin, genistein, tyr- 
phostin B46, herbimycin A, and isobutyl-1-methylxanthine 
(IBMX) were purchased from Calbiochem, La Jolla, CA. 
PTK assay activity kits were obtained from Life Technolo- 
gies, Gaithersburg, MD. All other chemicals used were of 
analytical grade. 
2.2. Cell culture 
A murine mesangial cell line (MES-13, cloned from 
mice transgenic for the early region of SV-40 virus, pas- 
sage 25) was obtained from ATCC. Mesangial cells were 
grown in DMEM containing 5% FBS, 1% glutamine- 
streptomycin-penicillin mixture, 44 mM NaHCO3, and 14 
mM Hepes in an atmosphere of 5% CO 2 and 95% air at 
37°C in a humidified incubator. Subcultures were made 
from confluent stock cultures by trypsinization in PBS 
containing 0.5 mM EDTA and 0.025% trypsin. A murine 
monocyte/macrophage cell line (J774.A1) was obtained 
from ATCC and cultured in RPMI 1640 supplemented 
with L-glutamine, penicillin/streptomycin, a d 10% FBS. 
2.3. Mesangial cell M-CSF gene expression: response of 
TNF-~ dose and incubation time 
Mesangial cells (5. 10 6) were grown in DMEM media 
containing 5% FBS at 37°C for 24 h to attain 75-80% 
confluence. The media was replaced with DMEM + 5% 
FBS containing various concentrations of TNF-c~ (0-200 
ng/ml) and incubated for 3 h at 37°C. After incubation, 
cell monolayers were washed and used for RNA isolation. 
The effect of incubation time on M-CSF mRNA expres- 
sion was performed by growing mesangial cells (5. 10 6) 
in DMEM media containing 5% FBS for 24 h. The 
medium was replaced with fresh DMEM + 5% FBS con- 
taining 25 Ixg/ml of TNF-a and incubated at 37°C for 
varying periods (0.5-24 h). After incubation, cell mono- 
layers were washed and used for RNA isolation. 
2.4. Mesangial cell M-CSF mRNA expression in response 
to TNF-ol activation: regulation through protein kinases 
The effect of PKC on mesangial cell gene expression 
was evaluated by incubating cells with either inducers or 
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inhibitors of PKC. Mesangial cells (5 • 106) were grown in 
DMEM containing 5% FI3S for 24 h to attain 75-80% 
confluence. The media was replaced with fresh DMEM + 
5% FBS containing the phorbol ester, phorbol-12-myri- 
state-13-acetate (PMA, 50 nM), an activator of PKC, and 
incubated for 3 h at 37°C. In other experiments, intra- 
cellular PKC was depleted by incubating mesangial cells 
with 50 nM PMA for 24 11 at 37°C. After predepletion of 
intracellular PKC, mesangial cells were stimulated by in- 
cubating them with either PMA (50 nM) or TNF-a (10 
ng/ml) for 3 h at 37°C. After the incubation, mesangial 
cell monolayers were washed (three times with PBS) and 
used for RNA isolation. Further experiments were per- 
formed to assess the effect of PKC on cellular gene 
expression by preincubating mesangial cells (5 × 106) at 
37°C for 1 h with a PKC inhibitor, calphostin C (100 nM). 
After preincubation with calphostin C, mesangial cells 
were stimulated for 3 h at 37°C with either 50 nM PMA or 
10 ng/ml TNF-a. After incubation, cell monolayers were 
washed (three times with PBS) and used for RNA isola- 
tion. 
Additional experiments, were performed by incubating 
mesangial cells in fresh DMEM + 5% FBS containing 
various cAMP generating agents including pertussis toxin 
(50 ng/ml), isoproterenol (5 IxM) or dbcAMP (1 mM) for 
3 h at 37°C. Experiment,; were also performed to deter- 
mine the effects of cAMP on TNF-(x-induced mesangial 
cell M-CSF gene expression by coincubating mesangial 
cells with TNF-a (10 ng/ml) and either dbcAMP (1 mM), 
forskolin (20 ~M), or perlussis toxin (50 ng/ml) for 3 h. 
In other experiments, mesangial cells were incubated for 3 
h with 0.5 mM IBMX, alone or in the presence of cAMP- 
generating substance. After the various incubations, 
mesangial cell monolayers were washed (three times with 
PBS), RNA isolated. 
Mesangiai cells (5. 113 '6) were  grown in DMEM con- 
taining 5% FBS for 24 h at 37°C to attain 75-80% 
confluence. The media was replaced with fresh DMEM + 
5% FBS and preincubated with PTK inhibitors including 
genistein (25 p,g/ml) for 15 min, herbimycin (10 IxM) for 
1 h or tyrphostin B (100 txM) for 2 h at 37°C. After 
preincubation with PTK inhibitors, mesangial cells were 
incubated in the presence ,or absence of TNF-~ (10 ng/ml) 
for 3 h at 37°C, washed (three times with PBS), and RNA 
isolated for Northern blot analysis. 
2.5. Mesangial cell M-CSF gene expression in response to 
TNF-a activation: effect ,of cycloheximide 
Additional studies were undertaken to determine the 
regulatory role of protein synthesis on TNF-c~-induced 
mesangial cell M-CSF gene expression. Mesangial cells 
(5 • 106) were grown in I3,MEM containing 5% FBS for 24 
h to attain 75-80% confluence. The medium was replaced 
with DMEM + 5% FBS, preincubated with cycloheximide 
(10 i~g/ml) for 2 h and stimulated with TNF-c~ (10 
ng/ml) for 3 h. After incubation, cell monolayers were 
washed, RNA isolated and used for Northern blot analysis 
for M-CSF mRNA expression. 
2.6. Assay of PKC actiuity 
PKC activity in mesangial cells stimulated with TNF-a, 
PMA or calphostin C + PMA was determined as described 
earlier by phosphorylation f histone [33]. Mesangial cells 
were treated with TNF-oL (10 ng/ml) or PMA (50 nM) in 
serum-free DMEM for 0.5-5 min. The cells were collected 
in 20 mM Tris, pH 7.4, containing 2 mM EGTA, 200 ixM 
sodium orthovanadate, 100 mM sodium pyrophosphate, 
300 nM p-nitrophenyl phosphate, 10 ~g/ml  aprotinin, 10 
t~g/ml eupeptin and 1 mM phenylmethylsulfonyl fluoride 
and then sonicated at 0°C for 10 s. The homogenate was 
centrifuged at 100000 X g for 60 min, and the PKC 
activity assayed in the membrane pellet by measuring the 
incorporation of [32p]phosphate into histone in the pres- 
ence or absence of phosphatidylserine (100 Ixg/ml) and 
PMA (10 txM). After incubating for 10 rain at 30°C, the 
reaction was stopped by adding 20 p.l of 12.5% trichloro- 
acetic acid and the mixture was spotted on Whatman 
phosphocellulose filters (p81, 2 cm). The filters were 
washed twice for 5 min with 75 mM phosphoric acid, once 
with 75 mM Na2HPO 4 for 5 min and then rinsed once 
with acetone. The filters were air dried and radioactivity 
measured. PKC activity was determined by the difference 
in activity obtained in the presence or absence of phos- 
phatidylserine/PMA. 
2.7. In vitro PTK actiL'ity assay 
PTK activity was measured in mesangial cells using 
cellular membranes and phosphorylation technique as de- 
scribed in a commercially available assay kit instructions. 
Membrane preparation and incubation conditions are briefly 
summarized. The mesangial cell monolayer was washed 
twice with cold PBS and scraped using a rubber scraper. 
Scraped cells were collected in small amount (1-2 ml) of 
membrane buffer (20 mM Hepes, pH 7.3, 250 mM su- 
crose, 1.0 mM EGTA), homogenized using a precooled 
Dounce homogenizer and the homogenate was centrifuged 
at 2000 rpm for 5 min. The supernatant was transferred to
fresh tubes and the membranes were pelleted after centri- 
fuging at 21 000 rpm for 20 min. Protein tyrosine kinase 
activity was measured by using RR-SRC peptide (12 amino 
acid sequence surrounding tyrosine phosphorylation site in 
pp60 ~rc) as a substrate at 30°C in the presence of 30 mM 
Hepes, pH 7.4, 10 mM MgC12, 1 mM DTT, 25 ~g/ml  
BSA, 0.15% Nonidet P-40, 0.07 mM sodium orthovana- 
date, 0.06 mM ATP, 4 IxCi [~/-32p]ATP in the presence or 
absence of herbimycin or genistein. The reaction was 
initiated by adding mesangial cell membrane preparations 
(15 Ixg protein) activated by incubation with TNF-o~ (10 
ng/ml) on ice for 30 min. After the incubation, 20 Ixl of 
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10% ice-cold trichloroacetic acid was added to precipitate 
the endogenous cellular proteins. The reaction mixture was 
incubated on ice for additional 10 rain and centrifuged at 
14000 x g for 10 min. A 35-1~I aliquot was spotted onto 
phosphocellulose disc (Whatman p81 phosphocellulose pa- 
per), washed 4 times with 180 mM phosphoric acid and 
rinsed once with 95% ethanol, air dried and radioactivity 
measured. The activity was expressed as pmol /mg pro- 
tein. 
2.8. Cytotoxici~ assay 
Cytotoxic effects of combination of TNF-c~ and cyclo- 
heximide on mesangial cells were examined by trypan blue 
exclusion and staining with crystal violet as described 
earlier [34]. Mesangial cells were treated with cyclohex- 
imide (10 I~g/ml) for 2 h and then with TNF-a (10 
ng/ml) for 3 h at 37°C. After the incubation, cells were 
trypsined and then stained with trypan blue. The number of 
viable and stained dead cells were counted under phase 
contrast microscope and the percent viability was calcu- 
lated. In cytotoxic assay using crystal violet staining, 
mesangial cells incubated with TNF-c~ and cycloheximide 
(as described above) were washed twice with PBS and 
stained with 0.2% crystal violet, The dye was eluted with 
33% acetic acid and the absorbance at 540 nm measured 
using a spectrophotometer. The cytotoxic effects were 
evaluated by comparing the incubation of mesangial cells 
with TNF-a + cycloheximide to those incubated with con- 
trol, TNF-a or cycloheximide alone. 
2.9. Western blot analyses 
Immunoblot analysis was performed to determine 
mesangial cell protein secretion of M-CSF. After mesan- 
gial cell incubation with TNF-ot, PMA, or specific kinase 
inhibitors (as described in various protocols), media was 
collected, concentrated (3- to 5-fold), and used for SDS- 
PAGE. Aliquots of media were heated at 100°C for 15 
min, applied to 12.5% polyacrylamide gels, and elec- 
trophoresed. A prestained SDS-PAGE standard (broad 
range, Bio-Rad) was also electrophoresed as a molecular 
weight marker. After electrophoresis, proteins were trans- 
ferred onto a nitrocellulose membrane using a transblot 
chamber with Tris buffer. Western blots were incubated 
with anti-murine M-CSF for 2 h at 25°C, membranes 
washed with PBS-Tween-20 for 1 h, and incubated with 
peroxidase-conjugated anti-IgG at 25°C for 90 rain. After 
washing, the membranes were incubated with a color 
reagent (50 mg 3,3'-diaminobenzidine, 0.1 ml H202 in 
100 ml PBS) for 15 min. Positive immunoreactive bands 
were quantitated ensitometrically and compared to con- 
trols. A similar protocol was used to determine PKC 
protein expression in a cell-lysate rather than incubation 
media. 
2. lO. Northern blot analysis 
After removing the media, mesangial cells were col- 
lected and washed three times with PBS. Total RNA was 
isolated from the cells using the protocol described by 
Chomczynski and Sacchi [35]. In brief, cells were homoge- 
nized with 4 M guanidium thiocyanate, total protein and 
DNA extracted with acid phenol, and RNA precipitated 
with isopropanol. After washing with ethanol, samples 
were dried under vacuum centrifugation and the amount of 
RNA quantitated by measuring the absorbance at 260 nm 
using a spectrophotometer. Thirty ~g of total RNA was 
loaded into individual wells of a 1.2% agarose gel contain- 
ing formaldehyde and electrophoresis performed. The RNA 
from the gel was transferred onto MSI nylon membranes 
using a capillary trans-blotting technique. The nylon mem- 
brane was UV-linked using a UV-Crosslinker (Fisher Sci- 
entific, Pittsburgh, PA). cDNA probes for M-CSF and 
GAPDH were used for hybridization after [32p]dCTP-la- 
belling by random oligonucleotide priming. The membrane 
was hybridized using a 32 P-labelled murine M-CSF cDNA 
probe. The membranes were washed three times for 30 
rain: first in 2 X SSC with 0.1% SDS at 25°C; second in 
0.2 x SSC with 0.1% SDS at 25°C; and third in 0.2 X SSC 
with 0.1% SDS at 55°C. Autoradiography was performed 
by exposing the blots to Kodak X-ray film with intensify- 
ing screens at -70°C. Blots were then rehybridized with a 
32p-labelled human GAPDH cDNA probe as an internal 
control to assess RNA quantity and integrity. Quantitation 
of mRNA signals was performed by densitometric scan- 
ning of autoradiographs and normalized with the GAPDH 
mRNA signal. 
2.11. Monocyte / macrophage proliferation assay 
A murine monocyte/macrophage cell line (J774.1) was 
grown for 24 h in 96-well culture plates (1 • 10  4 cells/well) 
in 200 ILl of RPMI 1640 media supplemented with L- 
glutamine, penicillin/streptomycin, and 5% FBS. After 
incubation, fresh media containing 60 ILl of control or 
TNF-c~-activated mesangial cell-conditioned media was 
added to the monocyte cultures and incubated for 48 h at 
37°C in a humidified 5% CO, atmosphere. 8 h before 
harvesting the cells, the individual wells were pulsed with 
0.5 txCi of [methyl-3H]thymidine. After pulsing, the cells 
were washed three-times with PBS (4°C), collected on 
glass wool fiber filters using a multiple sample cell har- 
vester, and radioactivity measured. Since TNF-c~ may 
directly influence monocyte/macrophage proliferation, ad- 
ditional proliferation studies were performed in the pres- 
ence of equivalent concentrations of exogenous TNF-a. 
Similar proliferation studies were performed utilizing satu- 
rating concentrations of murine anti-M-CSF to determine 
whether the observed changes in monocyte/macrophage 
proliferation were the result of M-CSF secreted by mesan- 
gial cells into the media in response to TNF-a activation. 
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2.12. Statistical analysis 
Results are presented as mean values + standard error 
(SE) for 3 -4  separate xperiments. Student's t-test was 
used to compare the means and a P value of less than 0.05 
was considered significant. 
3. Results 
In this study, SV-40 transformed murine mesangial 
cells were used as an in vitro model to examine the effect 
of TNF-ot on glomerular mesangial cell M-CSF mRNA 
expression. These transformed cells have been shown to 
exhibit similar characteristics to those of primary cultures 
of murine mesangial cells [36]. Besides maintaining nor- 
mal differentiation characteristics, transformed murine 
mesangial cells exhibit contractile properties in response to 
vasoactive substances and produce various cytokines anal- 
ogous to primary cultures of mesangial cells [37,38]. 
3.1. Effect of  TNF-ol on mesangial cell M-CSF mRNA 
expression 
Using transformed murine mesangial cells, studies were 
performed to examine the effect of exogenous TNF-a on 
M-CSF gene expression. Incubation of mesangial cells 
with varying concentrations of TNF-a (0-25 ng /ml )  in- 
duced steady-state M-CSF mRNA expression i  a dose-de- 
pendent manner (Fig. 1). Quantitative analysis of M-CSF 
mRNA expression by densitometric s anning and normal- 
ization with the GAPDH message suggested that the treat- 
ment of mesangial cells with as little as 0.5 ng /ml  of 
TNF-a stimulated M-CSF gene expression significantly 
when compared to control nonstimulated cells (50% in- 
crease over control) and the effect was maximum at a 
concentration of 5 ng /ml  of TNF-o~. Additional studies 
indicated that the preincubation of mesangial cells with 
TNF-oL (25 ng /ml )  for 3 h caused a maximal induction of 
M-CSF (4.0 kb) 
~ ~ ~ ~  m ~  GAPDH (1.3 kb) 
" + " + + + TNF-(x 
0.5 3 6 24 incubation time (h) 
Fig. 2. Effect of TNF-cx on the murine mesangial cell time kinetics of 
steady-state M-CSF mRNA expression byNorthern blot analysis. Mesan- 
gial cells were incubated in the presence or absence of TNF-a for 
varying time periods (0.5-24 h) and cells were analyzed for M-CSF 
mRNA expression asdescribed inSection 2. Northern blot is representa- 
tive of 3 separate experiments. 
mesangial M-CSF gene expression (Fig. 2). At 15 min 
(data not shown) and 30 min (Fig. 2), the incubation of 
mesangial cells with TNF-ot did not have stimulatory 
effects on M-CSF mRNA expression. The incubation of 
mesangial cells with TNF-a for 6 and 24 h decreased 
mesangial cell M-CSF message by 25% and 34%, respec- 
tively, when compared to 3 h incubation (Fig. 2). 
3.2. Effect of  PKC activation on TNF-a-induced N-CSF 
gene expression 
Additional studies were performed to identify the cellu- 
lar signal transduction pathways associated with TNF-a 
induced M-CSF mesangial cell gene expression. The incu- 
bation of mesangial cells with TNF-a for 3 h (Fig. 3A, 
lane 2) significantly increased M-CSF mRNA expression 
A 
M-CSF (4.0 kb) 
GAPDH (1.3 kb) 
1 2 3 4 5 6 
B 
M-CSF (4.0 kb) 
M-CSF (4.0 kb) 
GAPDH (1.3 kb) 
C 0.5 1 2 5 25 
TNF-(x (r,g/ml) 
Fig. 1. Effect of TNF-c~ on murine mesangial cell steady-state mRNA 
expression of M-CSF by Northern blot analysis. After incubation of
mesangial cells with TNF-a (0-25 ng/ml) for 3 h, cell monolayers were 
washed with PBS and RNA isolated, electrophoresed, and transferred 
onto nylon membranes. Northern blots were hybridized with 32 P-labelled 
murine DNA probe for M-CSF and then rehybridized with eDNA probe 
for GAPDH. Autoradiographs were developed by exposing blots to X-ray 
films. Northern blot is representative of 3separate experiments. 
GAPDH (1.3 kb) 
1 2 3 4 5 6 
Fig. 3. Role of PKC in basal and TNF-a-induced mesangial cell M-CSF 
gene xpression. I  (A), mesangial cells were incubated with the follow- 
ing substances: control (lane 1), TNF-ct for 3 h (lane 2), PMA for 24 h 
(lane 3), PMA for 3 h (lane 4), PMA for 24 h and activation with TNF-e~ 
for 3 h (lane 5), PMA for 24 h and activation with PMA for 3 h (lane 6). 
In (B), further studies were performed inthe presence orabsence ofPKC 
inhibitors. In these studies lanes represent the control incubation of 
mesangial ceils for 3 h (lane 1), PMA for 3 h (lane 2), TNF-c~ for 3 h 
(lane 3), control with calphostin C (lane 4), PMA and calphostin C (lane 
5), and TNF-a with calphostin C (lane 6). For more details, ee Section 
2. After incubation, mesangial cell monolayers were washed, RNA 
isolated, and used for Northern blot analysis. The Northern blot is 
representative of 3 separate experiments. 
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as compared to control (densitometric arbitrary values 
were control = 1.19 _+ 0.14, TNF-cx = 3.08 _ 0.01, P = 
0.0006). The incubation of mesangial cells for 3 h with 
PMA, an activator of protein kinase C (PKC), stimulated 
mesangial cell M-CSF mRNA message by 1.5- to 1.8-fold 
when compared to control (Fig. 3A, lane 4 compared to 
lane 1; densitometric arbitrary values were 1.8 _+ 0.1 and 
1.19_+ 0.14, respectively, P = 0.03). The depletion of 
mesangial cell PKC by prolonged incubation with PMA 
consistently decreased M-CSF gene expression (Fig. 3A, 
lane 3, densitometric value = 1.08 _+ 0.17) when compared 
to PMA stimulation (Fig. 3A, lane 4, densitometric value 
= 1.8 _+ 0.1, P = 0.02). The M-CSF mRNA message of 
PKC-depleted mesangial cells was similar to control cells 
and the densitometric arbitrary values were 1.08 _+ 0.17 
and 1.19 _+ 0.14, respectively. Additional studies indicated 
that the activation of PKC-depleted mesangial cells with 
PMA for 3 h did not induce mesangial cell M-CSF mRNA 
expression when compared to PKC-depleted mesangial 
cells (Fig. 3A, lanes 3 and 6; arbitrary quantitative values 
were 1.2 _+ 0.25 and 1.08 _+ 0.1). Utilizing PKC-depleted 
mesangial cells, experiments were performed to examine 
the role of PKC-activation in TNF-o~-induced mesangial 
cell M-CSF gene expression. As shown in Fig. 3A, the 
activation of PKC-depleted mesangial cells with TNF-c~ 
for 3 h partially inhibited M-CSF mRNA transcripts (12- 
22%) when compared to TNF-e~ activation of control cells 
(lane 5 compared to lane 2). Quantitative analysis of 
M-CSF mRNA signals from three separate xperiments 
that examined the effect of TNF-ot on PKC-depleted or 
control mesangial cells showed arbitrary values of 2.57 _-!- 
0.14 and 3.08 _+ 0.07. Although the incubation of TNF-ot 
with PKC-depleted mesangial cells showed only 17% inhi- 
bition of M-CSF message (lane 5 compared to lane 2), the 
difference was statistically significant at P < 0.05. Simi- 
larly, the preincubation of mesangial cells with calphostin 
C, a PKC inhibitor, decreased TNF-e~-induced M-CSF 
mRNA expression (Fig. 3B, lane 6 compared to lane 3, 
percent inhibition was 34.3 _+ 4.3%, P = 0.02) suggesting 
that, at least in part, PKC-activation regulates TNF-a-regu- 
lated M-CSF gene expression. Additional experiments were 
performed to validate whether the activation of mesangial 
cells with TNF-a, PMA or PKC-depletion altered cellular 
PKC by examining the effect of these interventions on 
PKC activity and protein expression. The results of these 
experiments indicated that the stimulation of mesangial 
cells with TNF-o~ (10 ng/ml) for 30 sec to 5 min in- 
creased PKC activity as measured by the phosphorylation 
of histone (PKC activity: control = 1.83 ___ 0.009 pmol /mg 
protein, TNF-o~ = 2.59 _ 0.05 pmol /mg protein, P = 
0.002). Similarly, the stimulation of mesangial cells with 
PMA markedly induced PKC activity. Additional experi- 
ments were performed to validate whether prolonged incu- 
bation of mesangial cells with PMA depleted PKC by 
measuring cellular protein expression using Western blot 
analysis. These studies indicated that the incubation of 
A 
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1 2 3 4 5 6 
B 
M-CSF (4.0 kb) 
GAPDH (1.3 kb) 
1 2 3 4 
Fig. 4. Effect of cAMP-generating substances on basal and TNF-cx- 
stimulated mesangial cell M-CSF gene expression. (A) Mesangial cells 
were incubated for 3 h with the following substances: control (lane 1), 
TNF-a (lane 2), pertussis toxin (lane 3), isoproterenol (lane 4), dbcAMP 
(lane 5), and TNF-a + dbcAMP (lane 6). After incubation, mesangial cell 
monolayers were washed, RNA isolated, and used for Northern blot 
analysis as outlined in Section 2. The Northern blot is representative of 3 
separate xperiments. (B) Mesangial cells were incubated for 3 h with 
control buffer (lane 1), TNF-c~ (lane 2), TNF-a + pertussis toxin (lane 3), 
and TNF-a + forskolin (lane 4). The Northern blot is representative of 3 
separate similar experiments. 
mesangial cells with PMA for 24 h, a protocol used to 
deplete cellular PKC, reduced PKC protein levels to unde- 
tectable as compared to control or PMA stimulation for 3 h 
(quantitative arbitrary densitometic values: PMA 3 h = 
0.07, PMA 24 h = undetectable). 
3.3. Effect of cAMP generating substances on mesangial 
cell M-CSF gene expression 
We further investigated the role of intracellular cAMP 
on mesangial cell M-CSF mRNA expression. Incubation of 
various cAMP generating substances (pertussis toxin, iso- 
proterenol) and dbcAMP, a cell-permeable analogue of 
cAMP, with mesangial cells for 3 h did not significantly 
stimulate steady-state mRNA transcripts when compared 
to controls (Fig. 4A, lane 3-5). Quantitative analyses by 
densitometric s anning of M-CSF Northern blot autoradio- 
graphs and normalization with GAPDH mRNA signals 
showed no stimulation of M-CSF mRNA message with 
cAMP generating substances and the average quantitative 
arbitrary values (from three experiments) for control and 
treatment of cells with TNF-a, pertussis toxin, isoprote- 
renol, and dbcAMP were 2.25 ___ 0.21, 6.55 + 0.85, 2.20 + 
0.04, 2.47 ___ 0.35, and 2.24_ 0.17, respectively. Addi- 
tional experiments were performed to determine the dose- 
response effects of dbcAMP on mesangial cell M-CSF 
mRNA transcripts. The data from these studies indicated 
that the incubation of mesangial cells with varying concen- 
trations of dbcAMP (0.5, 1, 2, and 3 mM) did not affect 
M-CSF mRNA expression (data not shown). Since intra- 
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cellular cAMP may undergo intracellular degradation, we 
examined the effect of adding cAMP-generating sub- 
stances in the presence of IBMX, a phosphodiesterase 
inhibitor, on mesangial cell M-CSF gene expression. The 
results from these studies showed that the addition of 
IBMX had no effect on M-CSF mRNA signal as compared 
to controls (data not shown), suggesting that intracellular 
cAMP may not serve as a second messenger for mesangial 
cell M-CSF synthesis. As an additional control study, the 
addition of IBMX alone to the incubation mixture did not 
affect M-CSF message (data not shown). 
3.4. Effect of cAMP generating substances on TNF-a-in- 
duced mesangial cell M-CSF mRNA expression 
Additional experiments were performed to examine 
whether an increase in intracellular cAMP would have any 
effect on TNF-et-induced mesangial cell M-CSF mRNA 
signal. Preincubation of mesangial cells with dbcAMP (0.5 
mM) inhibited TNF-et-indttced mRNA transcripts for M- 
CSF (Fig. 4A, lane 6 compared to lane 2; densitometric 
values were 2.86 _ 0.17 and 5.74 _ 0.85, P < 0.05). We 
further examined whether alternate cAMP generating 
mechanisms, uch as using pertussis toxin (an agent that 
catalyzes ADP-ribosylation of the G-protein that activates 
adenylate cyclase leading to elevation of intracellular 
cAMP) or forskolin (an agent that activates adenylate 
cyclase and increases cellular cAMP) would act similar to 
dbcAMP (a permeable analog of cAMP) in inhibiting 
TNF-ct-induced M-CSF mRNA expression. The results 
from these studies indicated that the coincubation of 
mesangial cells with TNF-~ (10 ng/ml) and either pertus- 
sis toxin (50 ng/ml) for 3 h or forskolin (20 ~M) for 3 h 
inhibited TNF-et-induced mesangial cell M-CSF mRNA 
expression by 80 and 55% respectivelly when compared to 
TNF-oL activation (Fig. 4B, lanes 3 and 4 as compared to 
lane 2). The densitometric values were for cells incubated 
with pertussis toxin + TNF-et = 0.13 + 0.006, forskolin + 
TNF-tx = 0.21 _ 0.006, and TNF-oL = 0.29 _ 0.003, P < 
0.005 for both treatments when compared to TNF-tx. 
3.5. Effect of PTK inhibitors on TNF-a-induced mesangial 
cell M-CSF mRNA expression 
The role of PTK in mesangial cell mRNA expression of 
M-CSF was examined by using various PTK inhibitors 
(i.e., genistein, herbimycin, tyrphostin). As shown in Fig. 
5, preincubation of mesangial cells with specific PTK 
inhibitors ignificantly inhibited TNF-c~-induced mesangial 
cell expression of M-CSF mRNA signal. Quantitative anal- 
yses by densitometric scanning of M-CSF Northern blots 
and normalization with GAPDH mRNA signals showed 
that the preincubation of mesangial cells with PTK in- 
hibitors nearly completely blocked TNF-oL-induced M-CSF 
mRNA expression and average quantitative arbitrary val- 
ues for control and treatment of cells with TNF-tx, TNF-tx 
M-CSF (4.0 kb) 
GAPDH (1.3 kb) 
1 2 3 4 5 6 7 8 
Fig. 5. Effect of PTK inhibitors on basal and TNF-~t-induced M-CSF 
mRNA expression by mesangial cells. Lanes represent the incubation of
mesangial cells for 3 h (lane l) and TNF-et (lane 2). Mesangial cells were 
preincubated with genistein for 15 min (lane 4), herbimycin for 1 h (lane 
6), and tyrphostin for 2 h (lane 8) prior to TNF-cx activation for 3 h. Lane 
3, 5, and 7 represent the preincubation f control mesangial cells with 
genistein, herbimycin, or tyrphostin respectively. After incubation, 
mesangial cell monolayers were washed, RNA isolated, and used for 
Northern blot analysis as outlined in Section 2. The Northern blot is 
representative of 3 separate experiments. 
plus genistein, TNF-e~ plus herbimycin, and TNF-o~ plus 
tyrphostin were 1.58, 2.94, 1.53, 1.46, and 1.27, respec- 
tively. PTK inhibitors also consistently inhibited the basal 
levels of M-CSF gene expression (40-64% as compared to 
control cells). Since PTK inhibitors markedly decreased 
TNF-et-induced mesangial cell M-CSF gene expression, 
we further validated the results by examining the effect of 
TNF-et in the presence or absence of PTK inhibitors on 
cellular PTK activity. These studies indicated that the 
activation of mesangial cells with TNF-ot significantly 
stimulated PTK activity when compared to control (P = 
0.004). Furthermore, preincubation of mesangial cell mem- 
branes with either genistein or herbimycin significantly 
inhibited TNF-a-induced PTK activity (PTK activity: 
TNF-et = 89.5 + 0.31 pmol/mg protein; TNF-et + 
genistein = 43.1 _ 2.44; TNF-et + herbimycin = 74.4 ___ 
3.06; P = 0.0001 and 0.002, respectively). 
3.6. Effect of TNF-ot, PMA and protein kinase inhibitors 
on mesangial cell M-CSF protein expression 
In order to correlate the alteration in mesangial cell 
M-CSF mRNA expression with protein synthesis, addi- 
tional studies were performed to examine the effect of 
TNF-a, PMA and various protein kinase inhibitors on 
mesangial cell M-CSF protein expression by Western blot 
analysis. These studies indicated that the incubation of 
mesangial cells with TNF-et or PMA (Fig. 6A, lanes 2 and 
4) increased M-CSF protein expression as compared to 
control (Fig. 6A, lane 1). Quantitative analysis performed 
by densitometric s anning of immunoblots showed that the 
induction of M-CSF protein expression by TNF-et (10 
ng/ml) and PMA (50 nM) was 41, and 43% respectively 
when compared to control. Preincubation of mesangial 
cells with calphostin C prior to TNF-~ activation de- 
creased mesangial cell M-CSF protein expression by 18% 
(Fig. 6A, lane 3 as compared to lane 2). Prolonged incuba- 
tion of mesangial cells with PMA for 24 h used to deplete 
PKC also showed a decreased M-CSF protein expression 
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Fig. 6. Effect of TNF-a, PMA, and protein kinase inhibitors on mesangial cell M-CSF protein expression. Mesangial cells were incubated with stimulators 
or inhibitors as described in the methods section. After the incubation, the media was collected, concentrated (3- to 5-fold) and used for Western blot 
analysis. (A) Lanes represent the incubation ofmesangial cells with control buffer (lane 1), TNF-a (10 ng/ml, lane 2), calphostin C + TNF-c~ (lane 3), 
and PMA (lane 4). In separate experiments, mesangial cells were incubated control buffer (lane 5), PMA (3 h, lane 6), and PMA (24 h, lane 7). (B) 
Additional experiments were performed by incubating mesangial cells for 3 h with control buffer (lane 1), TNF-a (lane 2), genistein +TNF-a (lane 3), 
dbcAMP + TNF-a (lane 4), forskolin + TNF-a (lane 5) and pertussis toxin + TNF-a (lane 6). The Western blots is representative of three separate 
experiments. 
when compared to the activation of cells with PMA for 3 h 
(Fig. 6A, lane 7 as compared to lane 6). Additional 
experiments were performed to examine the effect of PTK 
inhibitors and cAMP generating substances on TNF-cx 
induced M-CSF protein expression. The results from these 
studies indicated that the preincubation of mesangial cells 
with genistein, a representative inhibitor of PTK, markedly 
inhibited TNF-a-induced mesangial cell M-CSF protein 
expression (Fig. 6B lane 3 when compared to lane 2). 
Similarly, dbcAMP, forskolin and pertussis toxin (cAMP 
generating substances) also decreased mesangial cell TNF- 
stimulated M-CSF protein expression (Fig. 6B, lanes 4, 
5, and 6 when compared to lane 2). 
3.7. Effect of  cyclohexamine on TNF-oz-induced mesangial 
cell M-CSF gene expression 
To examine whether de novo protein synthesis is neces- 
sary for TNF-a-induced M-CSF gene expression, mesan- 
gial cells were preincubated with cycloheximide (10 
txg/ml) for 2 h prior to the addition of TNF-~ (25 
M-CSF (4.0 kb) 
GAPDH (1.3 kb) 
" "1" Cycloheximide (10 p,g/ml) 
4" -I- TNF-~ (25 ng/ml) 
Fig. 7. Northern blot analysis of the effect of cycloheximide onTNF-a- 
induced mesangial cell M-CSF mRNA expression. Mesangial cells were 
preincubated with cycloheximide (10 ~g/ml) for 2 h prior to TNF-c~- 
activation for 3 h. Additional descriptions are given in the text. Northern 
blot is representative of 3 separate experiments. 
ng/ml).  The inhibition of cellular protein synthesis by 
cycloheximide significantly decreased TNF-a-induced 
mesangial cell M-CSF gene expression without altering the 
GAPDH mRNA message (Fig. 7). Since the incubation of 
various cells (e.g., human HeLa and murine L(S) cells) 
with both cycloheximide and TNF-a in earlier studies has 
been shown to exhibit cytotoxicity [39], the effects of the 
combination of cycloheximide and TNF-a on mesangial 
cell viability by trypan blue exclusion criteria and staining 
with crystal violet was examined. The results from these 
studies indicated that the preincubation of mesangial cells 
with cycloheximide for 2 h prior to TNF-o~ activation for 3 
h did not affect the viability of mesangial cells as assessed 
by both trypan blue exclusion technique (96-99% viability 
when compared to control) as well as by crystal violet 
staining method (97-102% viability as compared to con- 
trol). Thus, these data clearly suggest that the observed 
inhibition of M-CSF expression in mesangial cells treated 
with both TNF-a and cycloheximide was not due to 
cellular toxicity rather specific metabolic effects of protein 
synthesis on M-CSF mRNA expression. 
3.8. Effect of  TNF-e~-actir'ated mesangial cell conditioned 
media on monocyte proliferation 
Since the results of Northern blot analyses indicated 
that the activation of mesangial cells with TNF-a stimu- 
lated the gene of a cytokine associated with monocyte 
proliferation, further studies were performed to examine 
the ability of TNF-a-activated mesangial cell-conditioned 
media to stimulate the in vitro proliferation of monocytes 
by using [3H]thymidine incorporation into cellular DNA. 
Incubation of murine monocyte/macrophages with condi- 
tioned media obtained from mesangial cells activated with 
TNF-c~ (0-25 ng/ml)  stimulated monocyte proliferation 
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Fig. 8. Effect of TNF-a-activatezl mesangial cell conditioned media on 
monocyte/macrophage proliferation. Conditioned media were obtained 
from the incubation of mesangia] cells with 0, 0.5, 5, and 25 ng /ml  of 
TNF-cx. Aliquots of mesangial ,:ell conditioned media (120 I~1) were 
added to murine monocyte/macrophage cultures (J774.Al, a cell line) 
and incubated in RPMI-1640 media for 48 h at 37°C. Eight hours before 
harvesting, the individual wells were pulsed with [3H]thymidine (0.5 
p~Ci), washed with PBS, and cells collected on glass wool fiber filters and 
radioactivity measured as indict.ted in (A). Similar experiments were 
performed in the presence of saturating concentrations of murine anti-M- 
CSF (B). Results represent he incorporation of [3H]thymidine into 
cellular DNA as an index of cell proliferation. Values are mean + S.E. of 
3 individual experiments. P-values represent comparisons between TNF- 
c~-activated mesangial cell supernatant and the respective control. 
dose-dependently as measured by the incorporation of 
[3H]thymidine into cellular DNA (Fig. 8A). Additional 
studies were performed to determine the contribution of 
M-CSF secreted by TNF-e~-activated mesangial cells to 
stimulate monocyte proliferation by using a specific murine 
anti-M-CSF. These studies indicated that anti-M-CSF at- 
tenuated monocyte proliferation i duced by control as well 
as TNF-e~-stimulated mesangial cell conditioned media by 
20-54% (Fig. 8B). Since TNF-a present in the mesangial 
cell conditioned media may independently influence mono- 
cyte proliferation, additional studies were performed with 
equivalent concentrations of exogenous TNF-a to examine 
monocyte proliferation. These studies indicated that the 
incubation of equivalent concentrations of exogenous 
TNF-cx (5 and 25 ng/ml) with murine monocyte/macro- 
phages (in the absence of TNF-a-activated conditioned 
media) did not alter monocyte proliferation as assessed by 
[3H]thymidine incorporation i to cellular DNA (CPM val- 
ues: control = 29 479 _ 2206; TNF-cx, 5 ng/ml = 29 077 
_ 1527; TNF-a, 25 ng/ml = 28 122 + 2400). These data 
suggest hat the ability of mesangial cell conditioned me- 
dia to induce monocyte proliferation was the result of 
mesangial cell secretory products. 
4. Discussion 
The present studies show that the activation of mesan- 
gial cells with TNF-a increases the gene expression and 
protein synthesis of M-CSF, a specific cytokine involved 
in monocyte differentiation i to macrophages, migration, 
and proliferation supporting previous observations regard- 
ing the role of proinflammatory c tokines in M-CSF stim- 
ulation by mesangial cells [40-43]. Additional studies 
suggested a pathobiological role for TNF-a in the devel- 
opment of glomerular injury [28,44,45]. Although TNF-a 
has been shown to stimulate various intracellular signaling 
mechanisms (e.g., activation of PKC, cAMP-dependent 
protein kinase A, protein tyrosine kinase; [46-53]), the 
cellular signal transduction pathways that regulate the gene 
expression of cytokines associated with monocyte adhe- 
sion, transmigration, and proliferation are not clearly delin- 
eated in mesangial cells. 
In the present investigation, we explored the possibility 
that PKC, PTK, or cAMP may serve as signaling pathways 
in TNF-a-mediated stimulation of mesangial cell M-CSF 
gene expression. The involvement of PKC in TNF-a-in- 
duced mesangial cell M-CSF expression was assessed by 
using a PKC-depletion approach and by using calphostin 
C, a specific PKC inhibitor. In three separate xperiments, 
the incubation of PKC-depleted mesangial cells with TNF- 
for 3 h inhibited mesangial cell M-CSF transcripts by 
12-22% (P < 0.05) when compared to TNF-o~ activation 
of control mesangial cells. Based on the earlier reports 
regarding the observations that PMA or activators of PKC 
rapidly decreased TNF-~ binding affinity in a variety of 
cells [54], it is likely that prolonged incubation of mesan- 
gial cells with PMA used to deplete PKC in our studies, 
through decreased TNF-ot binding, may have contributed 
to the observed partial inhibition of TNF-a-induced M-CSF 
mRNA expression (12-22%). Since prolonged incubation 
of mesangial cells with PMA (24 h), an approach used to 
deplete PKC, completely abolished cellular PKC protein 
expression and in these PKC-depleted cells, PKC may not 
be available for modulating TNF-a binding and its associ- 
ated cellular esponses. Thus, based on these observations, 
it is unlikely that prolonged incubation of mesangial cells 
with PMA through decreased TNF-o~ binding affinities or 
receptor shedding during PKC-down regulation used in 
this investigation could contribute for the partial inhibition 
of TNF-o~ mediated M-CSF mRNA expression. Addition- 
ally, mesangial cells preincubated with calphostin C, a 
specific PKC inhibitor, decreased TNF-a-induced mesan- 
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gial cell M-CSF gene expression (25-35% compared to 
TNF-e~ activation). Based on these PKC-depletion experi- 
ments and studies using a PKC inhibitor, we suggested that 
PKC activation, at least in part, may act as a regulatory 
signaling pathway in mesangial cell M-CSF expression. 
Our results are in agreement with previous observations in
murine astrocytes indicating that proinflammatory cy- 
tokines, including TNF-c~, induced M-CSF mRNA mes- 
sage that was regulated through PKC-dependent mecha- 
nisms [55]. However, by using PKC-depletion protocols, it 
was shown that M-CSF synthesis in fibroblasts timulated 
by acute phase response mediators (i.e., IL-I, TNF-a and 
IL-6) was independent of PKC stimulation [56]. Although 
the observations made in this study and earlier investiga- 
tions support he involvement of PKC in cellular M-CSF 
gene expression, the regulatory role of PKC in proinflam- 
matory cytokine-mediated M-CSF synthesis i  variable and 
appears to be cell-type specific. 
Since the activation of cells with proinflammatory c - 
tokines (including IL-1 and TNF-e~) stimulated protein 
tyrosine phosphorylation f membrane and cytosolic pro- 
teins [50-52], we proposed that PTK may serve as a 
second messenger for TNF-c~-induced mesangial M-CSF 
expression. Preincubation of mesangial cells with various 
PTK inhibitors (i.e., genistein, herbimycin, and tyrphostin) 
blocked TNF-et-induced M-CSF mRNA message. Addi- 
tionally, these PTK inhibitors decreased basal levels of 
mesangial cell M-CSF by 40-64%. These results clearly 
suggest hat PTK-mediated pathways play a fundamental 
role in TNF-a-induced mesangial cell M-CSF gene expres- 
sion. In agreement with these results, we have recently 
shown that TNF-c~-mediated mesangial cell ICAM-1 and 
MCP-I gene expression was also regulated through cellu- 
lar pathways involving PTK activation (Kamanna, V.S., 
Pai, R., Kirschenbaum, M.A., unpublished observations). 
Similarly, IL-1 stimulated mesangial cell MCP-1 expres- 
sion was also shown to be mediated through PTK-depen- 
dent pathways [57]. 
Previously, it has been shown that agents that increased 
intracellular cAMP decreased basal levels of mesangial 
cell M-CSF synthesis and attenuated gene expression in 
mesangial cells activated with TNF-a, IFN-~/, and im- 
mune-complexes [41]. In the present investigation, we 
confirmed the previous observations regarding the role of 
cAMP as a negative regulator for mesangial cell M-CSF 
expression. The preincubation of mesangial cells with 
cAMP generating substances, pertussis toxin, an agent hat 
catalyzes ADP-ribosylation of a subunit of the G protein 
that activates adenylyl cyclase leading to elevation of 
intracellular cAMP, did not stimulate mesangial cell M- 
CSF mRNA expression. Additionally, isoproterenol, an 
activator of receptors coupled to G~ protein and adenylyl 
cyclase, and dbcAMP, a cell permeant analog of cAMP, 
also did not affect mesangial cell M-CSF message. As 
intracellular cAMP may undergo degradation, further ex- 
periments were performed to examine the effect of 
cAMP-generating substances in the of presence of IBMX, 
a potent phosphodiesterase inhibitor, on mesangial cell 
M-CSF expression. The data from these studies indicated 
that the presence of IBMX with cAMP generating sub- 
stances did not influence mesangial cell M-CSF signal. 
The results from these studies revealed that the increase in 
mesangial cell cAMP had no stimulatory effect on M-CSF 
steady-state mRNA expression. Additional experiments 
were performed to determine whether cAMP had any 
effect on TNF-a-induced M-CSF expression. The coin- 
cubation of dbcAMP, forskolin, or pertussis toxin with 
TNF-c~ for 3 h with mesangial cells markedly inhibited 
TNF-o~-induced mesangial cell M-CSF mRNA signal. 
Studies examining the role of protein synthesis on 
TNF-c~-induced mesangial cell M-CSF expression were 
performed and indicated that the preincubation of mesan- 
gial cells with cycloheximide, an inhibitor of protein syn- 
thesis, completely blocked TNF-c~-mediated increase in 
mesangial cell M-CSF mRNA signal suggesting that intact 
protein synthetic machinery is required for TNF-c~-induced 
M-CSF expression. These observations in mesangial cells 
are consistent with earlier studies in articular cartilage and 
chondrocytes demonstrating that the inhibition of protein 
synthesis by cycloheximide abolished M-CSF expression 
stimulated by proinflammatory c tokines [58]. However, 
earlier studies using human monocytes or cord blood 
mononuclear cells have indicated that the treatment of 
these cells with cycloheximide induced constitutive and 
GM-CSF stimulated M-CSF gene expression [59,60]. These 
authors have suggested that the induction of M-CSF by 
protein synthesis inhibition may be associated with stabi- 
lization of mRNA transcripts through labile proteins that 
can regulate transcript stability or inhibition of specific 
RNases. In light of our observations and those in other 
cells, the mechanism of action of cycloheximide to inhibit 
TNF-a-induced mesangial cell M-CSF expression cannot 
be determined precisely and requires further studies related 
to transcriptional nd translational mechanism. 
Thus, the stimulation of M-CSF expression appears to 
occur in response to many cytoregulatory peptides and 
circulating macromolecules. For example, we [38,61] and 
others [62,63] have shown that the in vitro activation of 
mesangial or aortic vascular cells with atherogenic lipopro- 
teins stimulated the expression of MCP-1 and M-CSF and 
augmented monocyte chemotaxis and proliferation. Simi- 
larly, circulating immune-complexes al o were capable of 
interacting with mesangial cells and increasing their ability 
to synthesize monocyte chemoattractants and colony stim- 
ulating factors associated with monocyte-mediated 
glomerular injury [40,41]. In the present and previous 
studies it has been noted that intracellular cAMP acted as 
an inhibitor of proinflammatory c tokine-induced mesan- 
gial cell expression of M-CSF, MCP-1 and ICAM-I 
[41,64,65]. Thus, the synthesis of M-CSF and its associ- 
ated cellular actions may depend upon a critical balance 
between proinflammatory c tokines and macromolecules 
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(including eicosanoids, atherogenic lipoproteins, immune 
complexes, etc.) and cellular M-CSF gene expression in- 
hibitors ( including cAMP, JLsoproterenol, PGE 2, forskolin, 
etc.). 
In summary, we have shown that the activation of 
mesangial cells with TNF-a  stimulated both M-CSF 
mRNA transcripts and the secretion of biologically-active 
M-CSF into the culture media. The enhanced monocyte 
proliferation associated with TNF-c~ stimulation of mesan- 
gial cells was blocked by specific murine anti-M-CSF. The 
TNF-a- induced mesangial cell M-CSF gene expression 
was regulated by signal transduction pathways mediated 
by PTK, and at least, in part, by PKC. Increased intra- 
cellular cAMP mediated by activators of adenylate cyclase 
and a cell permeable analog of cAMP did not induce 
mesangial cell M-CSF gene expression. However, agents 
that increased intracellular cAMP blocked TNF-a- induced 
mesangial cell M-CSF mRNA expression. Thus, based on 
these observations, we suggest hat the inhibit ion of TNF-a  
action by neutralizing antibodies, functional antagonists, or 
pharmacologic elevations of cAMP levels in vivo may 
provide potential therapeutic approaches by down-regulat- 
ing the sustained expression of adhesion molecules, mono- 
cyte chemoattractants and hematopoietic colony stimulat- 
ing factors involved in inf lammatory reactions leading to 
irreversible glomerular injury. Since these in vitro observa- 
tions may not be directly extrapolated to an in vivo system, 
further in vivo studies are warranted to determine the 
pathobiological significance of TNF-a  and cAMP-mimet-  
ics on the genesis and progression of glomerular injury. 
Acknowledgements 
This investigation was supported by a Merit Review 
from the Department of Veterans Affairs and an Institu- 
tional Fellowship Award from the National Kidney Foun- 
dation of Southern California. The authors thank Ms. 
Kathy Arndt for her secretarial assistance in the prepara- 
tion of this manuscript. 
References 
[1] Sterzel, R.B., Schulze-Lohoff, E. and Marx, M. (1993) Kidney Int. 
43, Suppl. 39, $26-$31. 
[2] Schreiner, G.F. (1991) Sem. Nephrol. 11,268-275. 
[3] Cattell, V. (1994) Kidney Int. 45, 945-952. 
[4] Brenner, B.M., Zata, R. and lchikawa, I. (1986) In: The Kidney, 3rd 
Edn. (Brenner, B.M. and Rector, F.C., eds.), p. 107, W.B. Saunders, 
Philadelphia. 
[5] Magil, A.B. and Cohen, A.H. (1989) Lab. Invest. 61,404-409. 
[6] Hooke, D.H., Hancock, W.W., Gee, D.C., Kraft, N. and Atkins, 
R.C. (1984) Clin. Nephrol. 22, 163-168. 
[7] Nolasco, F.E.B., Cameron, J.S., Hartley, B., Coelho, A., Hildreth, 
G. and Reuben, R. (1987) Kidney Int. 31, 1160-1166. 
[8] Schreiner, G.F., Rovin, B.H. and Lefkowith, J.B. (1989) J. Immunol. 
143, 3192-3199. 
[9] Schreiner, G.F., Cotran, R.S., Pardo, V. and Wnanue, E.R. (1978) J. 
Exp. Med. 147, 369-384. 
[10] Diamond, J.R., Pesek, I., Ruggieri, S. and Karnovsky, M.J. (1989) 
Am. J. Physiol. 257, F789-F807. 
[11] Saito, T. and Atkins, R.C. (1990) Kidney Int. 37, 1076-1083. 
[12] Diamond, J.R., Pesek, I., McCarter, M.D., Karnovsky, M.J. (1989) 
Am. J. Pathol. 135, 711-718. 
[13] Kasiske, B.L., O'Donnell, M.P., Schmitz, P.G., Kim, Y. and Keane, 
W.F. (1990) Kidney Int. 37, 880-891. 
[14] Karnanna, V.S., and Kirschenbaum, M.A., (1993) Am. J. Nephrol. 
13, 53-58. 
[15] Schlondorff, D., (1995) Kidney Int. 47, Suppl. 49, $44-$47. 
[16] Brady, H.R., Denton, M.D., Jimenez, W, Takata, S., Palliser, D. and 
Brenner, B.M. (1992) Kidney Int. 42, 480-487. 
[17] Stahl, R.A.K., Thaiss, F., Disser, M., Helmchen, U., Hora, K. and 
Schlondorff, D. (1993) Kidney Int. 44, 1036-1047. 
[18] Rovin, B.H., Rumancik, M., Tan, L. and Dickerson, J. (1994) Lab. 
Invest. 71,536-542. 
[19] Yui, M.A., Brissette, W.H., Brennan, D.C., Wuthrich, R.P., and 
Rubin-Kelley, V.E. (1991) Am. J. Pathol. 139, 255-261. 
[20] Neugarten, J., Feith, G.W., Assmann, K.J.M., Shan, Z., Stanley, 
E.R. and Schlondorff, D. (1995) J. Am. Soc. Nephrol. 5, 1903-1909. 
[21] Stanley, E.R., Guilbert, L.J., Tushinski, R.J. and Bartelmez, S.H. 
(1983) J. Cell. Biochem. 21, 151-159. 
[22] Wang, J.M., Griffin, J.D., Rambaldi, A., Chen, Z.G. and Mantovani, 
A. (1988) J. Irnmunol. 14l, 575-579. 
[23] Mori, T., Bartocci, A., Satriano, J., Zuckerman, A., Stanley, E.R., 
Santiago, A. and Schlondorff D. (1990) J. Immunol. 144, 4697-4702. 
[24] Mufson, R.A., Aghajanian, J., Wong, G., Woodhouse, D. and 
Morgan, A.C. (1989)Cell Immunol. 119, 182-192. 
[25] Jadus, M.R., Pai, R., Horansky, E., Wepsic, H.T., Kirschenbaum, 
M.A. and Kamanna, V.S. (1994) Biochim. Biophys. Acta 1224, 
181-188. 
[26] Bloom, R.D., Florquin, S., Singer, G.G., Brennan, D.C. and Rubin- 
Kelley, V.E. (1993) Kidney Int. 43. 1000-1009. 
[27] Pai, V., Pai, R., Kamanna, V.S., and Kirschenbaum, M.A. (1994) J. 
Am. Soc. Nephrol. 5, 727A. 
[28] Egido, J., Gomez-Chiarri, M., Ortiz, A., Bustos, C., Alonso, J., 
Gomez-Guerrero, C. Gomez-Garre, D., Lopez-Armada, M.J., Plaza, 
J. and Gonzalez, E. (1993) Kidney Int. 43, Suppl. 39, $59-$64. 
[29] Tipping, P.G., Leong, T.W. and Holdsworth, S.R. (1991) Lab. 
Invest. 65, 272-279. 
[30] Diamond, J.R. and Pesek, I. (1991) Lab. Invest. 64, 21-28. 
[31] Suranyi, M.G., Guasch, A., Hall, B.M. and Myers, B.D. (1993) Am. 
J. Kidney Dis. 21, 251-259. 
[32] Boswell, J.M., Yui, M.A., Burt, D.W. and Kelley, V.E. (1988) J. 
Immunol. 141, 3050-3054. 
[33] Qiu, Z-H., and Leslie, C.C., (1994) J. Biol. Chem. 269, 19480- 
19487. 
[34] Ruggiero,V., Tavernier, J., Fiers, W., and Baglioni, C. (1986) J. 
Immunol. 136, 2445-2450. 
[35] Chomczynski, P. and Sacchi, N. (1989) Anal. Biochem. 162, 156- 
160. 
[36] MacKay, K, Striker, L.J., Elliot, S., Pinkert, C.A., Brinster, R.L. and 
Striker, G.E. (1988) Kidney Int. 33, 677-684. 
[37] Satriano, J.A., Shuldiner, M., Hora, K., Xing, Y., Shan, Z. and 
Schlondorff, D. (1993) J. Clin. Invest. 92, 1564-1571. 
[38] Pai, R., Kirschenbaum, M.A. and Kamanna, V.S. (1995) Kidney Int. 
48,1254-1262. 
[39] Johnson, S. E., and Baglioni, C. (1988) J. Biol. Chem. 263, 5686- 
5692. 
[40] Hora, K., Satriano, J.A., Santiago, A., Mori, T., Stanley, E.R., Shan, 
Z. and Schlondorff, D. (1992) Proc. Natl. Acad. Sci. USA. 89, 
1745-1749. 
[41] Satriano, J.A., Hora, K., Shan, Z., Stanley, E.R., Mori, T. and 
Schlondorff, D. (1993)J. Immunol. 150, 1971-1978. 
172 V.S. Kamanna et al. / Biochimica et Biophysica Acta 1313 (1996) 161-172 
[42] Zoja, C., Wang, J.M., Bettoni, S., Sironi, M., Renzi, D., Chiaffarino, 
F., Abboud, H.E., Damme, LV., Montovani, A., Remuzzi, G. and 
Rambaldi, A. (1991) Am. J. Pathol. 138, 991-1003. 
[43] Sherry, B. and Cerami, A. (1988) J. Cell. Biol. 107, 1269-1277. 
[44] Hruby, Z.W., Shirota, K., Jothy, S. and Lowry, R.P. (1991) Kidney 
Int. 40, 43-51. 
[45] Tomosugi, N.I., Cashman, S.J., Hay, H., Pusey, C.D., Evans, D.J., 
Shaw, A. and Rees, A.J. (1989) J. Immunol. 142, 3083-3090. 
[46] Vilcek, J. and Lee, T.H. (1991) J. Biol. Chem. 266, 7313-7316. 
[47] Heller, R.A. and Kronke, M. (1994) J. Cell. Biol. 126, 5-9. 
[48] Zhang, Y., Lin,J.-X., Yip, Y.K. and Vilcek, J. (1988) Proc. Natl. 
Acad. Sci. USA 85, 6802-6805. 
[49] Shiroo, M and Matsushima, K.(1990) Cytokine 2, 13-20. 
[50] Guy, G.R., Chua, S.P., Wong, N.S., Ng, S.B. and Tan, Y.H. (1991) 
J. Biol. Chem. 266, 14343-14352. 
[51] Donato, N.J., Gallick, G.E., Steck, P.A. and Rosenblum, M.G. 
(1989) J. Biol. Chem. 264, 20474-20481. 
[52] Kohno, M., Nishizawa, N. Tsujimoto, M. and Nomoto, H. (1990) 
Biochem. J. 267, 91-98. 
[53] Helper, J.R., Earp, H.S., and Harden, T.K. (1988) J. Biol. Chem. 
263,7610-7619. 
[54] Unglaub, R., Maxeiner, B., Thoma, B., Pfizenmaier, K., and 
Scheurich, P. (1987) J. Exp. Med. 166, 1788-1797. 
[55] Thery, C., Stanley, E.R. and Mallat, M. (1992) J. Neurochem, 59, 
1183-1186. 
[56] Mantovani, L., Henschler, R., Brach, M.A., Mertelsmann, R.H. and 
Herrmann, F. (1991) FEBS Lett. 280, 97-102. 
[57] Rovin, B.H. and Tan, L.C. (1994) Kidney Int. 46, 1059-1068. 
[58] Campbell, I.K. Ianches, G, and Hamilton, J.A. (1993) Biochim. 
Biophys. Acta 1182, 57-63. 
[59] Ernst, T.J., Ritchie, A.R, Demetri, G.D., and Griffin, J.D. (1989) J. 
Biol. Chem 264, 5700-5703. 
[60] Suen, Y., Lee, S.M., Schreurs, J., Knoppel, E., and Cairo, M.S. 
(1994) Blood 84, 4269-4277. 
[61] Kamanna, V.S., Pai, R., Roh, D.D., and Kirschenbaum M.A. (1996) 
Lab. Invest., in press. 
[62] Rajavashisth, T.B., Andalibi, A., Territo, M.C., Berliner, J.A., Navab, 
M., Fogelman, A.M. and Lusis, A.J. (1990) Nature 344, 254-257. 
[63] Liao, F., Berliner, J.A., Mehrabian, M., Navab, M., Demer, L.L., 
Lusis, A.J. and Fogelman, A.M. (1991) J. Clin. Invest. 87, 2253- 
2257. 
[64] Pai, R., Ha, H., Kirschenbaum, M.A., and Kamanna, V.S. (1996) J. 
Am. Soc. Nephrol., in press. 
[65] Pai, R., Bassa, B., Kirschenbaum, M.A., and Kamanna, V.S. (1996) 
J. Immunol. 156, 2571-2579. 
